Patent Leaderboard
USPTO Patent Rankings Data through Dec 31, 2025
Home › Engineered dendritic cells and uses for the treatment of cancer

Engineered dendritic cells and uses for the treatment of cancer

US Patent 9675642 · Granted Jun 13, 2017

Assignee

Inventors

View full patent text on Google Patents →

More Patents by These Inventors

De-duplicating transaction records using targeted fuzzy matching2025
Methods of treating EGFRvIII expressing glioblastomas2024
System and method for repeatable and interpretable divisive analysis2024
Methods of treating glioblastomas2024
H3.3 CTL peptides and uses thereof2024
Treatment of cancer using humanized anti-EGFRvIII chimeric antigen receptor2024
EphA2 T-cell epitope agonists and uses therefore2023
Peptide analogs capable of enhancing stimulation of a glioma-specific CTL respon2023
Peptide analogs capable of enhancing stimulation of a glioma-specific CTL respon2023
Catalog enablement data for supplier systems based on community activities2023
System and method for repeatable and interpretable divisive analysis2022
Matching past post-approved transactions with past pre-approved transactions usi2022